EU Drug Market: Amphetamine — Figures

  1. Amphetamine, methamphetamine and MDMA are from the same chemical family (Introduction)
  2. Amphetamine tablets with the Captagon logo (Introduction)
  3. Distribution of global quantities of amphetamine seized, 2017-2021 (Global context)
  4. Simplified general schema of amphetamine production (Production)
  5. Number of amphetamine production sites dismantled in the EU, 2019-2021 (Production)
  6. Location of sites related to amphetamine production in the EU, 2019-2021 (Production)
  7. Main precursors and essential chemicals needed for the synthesis of amphetamine, methamphetamine, MDMA and MDA via the Leuckart method (Production)
  8. Quantities of seized chemicals associated with the Leuckart method in the EU, 2012-2021 (Production)
  9. Quantities of seized chemicals that may be associated with the nitrostyrene method in the EU, 2012-2021 (Production)
  10. Number of amphetamine seizures in the EU, Norway and Türkiye, 2011-2021 (Trafficking and supply)
  11. Quantity of amphetamine seized in the EU, Norway and Türkiye, 2011-2021 (Trafficking and supply)
  12. Reported European shipping countries for amphetamine listings on major darknet markets, 2021 (Trafficking and supply)
  13. Retail-level price and purity of amphetamine in a selection of EU Member States and Norway, 2018-2021 (Prices and purities)
  14. Estimated average retail price per pure gram in selected EU Member States and Norway, 2018-2021 (Prices and purities)
  15. Relative geographical distribution of amphetamine as detected in wastewater in European cities, 2022 (daily mean) (Retail markets)
  16. In the last 12 months, how did you usually buy amphetamine? (Retail markets)
  17. In the last 12 months, how was the amphetamine usually delivered to you? (Retail markets)
  18. Percentage of detection of amphetamine in used syringes in selected cities in the EU, 2017-2022 (Effects, risks and harms of use)
  19. Proportion of the acute drug-toxicity presentations with amphetamine involved (Effects, risks and harms of use)
Top